The T-Body Approach: From the Mouse Cage to the Patient’s Bed

Prof of Immunology, Chair of Immunology Research
Tel Aviv Sourasky Medical Center,Tel Aviv, Israel

1976 - 1978 -    Research Fellow, Department of Chemical Immunology, The Weizmann Institute
1979 - 1982     Senior Scientist, Dept. of Chemical Immunology,The Weizmann Institute
1982 - 1993 -    Associate Professor (tenure), The Weizmann Institute of Science.
1983 - 1984 -    Sabbatical at DNAX Research Institute for Molecular Biology, Palo Alto, CA.
1991 - 1992 -    Sabbatical year at the Surgery Branch, National Cancer Institute, Bethesda
1994 - 2011    Professor, The Weizmann Institute of Science.
1995 - 1998    Chairman, Department of Immunology, The Weizmann Institute of Science
2002 - 2005    Chairman, Department of Immunology, The Weizmann Institute of Science.
2011- Professor Emeritus, Department of Immunology, The Weizmann Institute
2012 - Chairman, Immunology Research, Tel Aviv Sourasky Medical Center
2012 - Guest Professor, The Faculty of Medicine, Tel Aviv University

Honors and Awards:
1972 - John F. Kennedy Memorial Scholarship.
1973 - Fullbright-Hays Scholarship
1973 - World Health Organization, Fellowship for Cancer Research and Training     
1977 - European Molecular Biology Organization Fellowships.
1978 - Incumbent of the Recanati, Career Development Chair in Cancer Research.
1984- Incumbent of the Renete & Marshall Ezralow Chair in Chemical and Cellular Immunology.
1996, 1997, 1999-02 Cap Cure Awards for Prostate Cancer Research
2010 - Pioneer Award for the development of the CAR/T-body approach.

Service on Institutional, Governmental and International Committees:
Founder and Chairman of the Israeli Society of Gene Therapy
Member of various Weizmann Institute promotion committees
Board member of the European Society of Gene Therapy
Head Committees of the Israeli Scientific Fund
Advisor to the Israeli Health Ministry on regulatory issues
Head Various Granting Committee of the Israeli Ministry of Science

Fields of Expertise:
Cancer Immunotherapy
Adoptive Cell Therapy
Cells, Antibodies and Gene Engineering
Regulatory T Cells Mediated Suppression of Inflammatory Diseases
Allergy
Publications: 210; Patents:13